Data from the World Health Organization show that less than 1% of vaccines used in Africa are manufactured on the continent. Many developing nations depend on developed nations to obtain life-saving vaccines. The African Union aims for the region to develop, produce and supply more than 60% of the vaccine doses required on the continent by 2040, an ambitious target that observers say requires bold investment, highly trained skilled labor, intense quality assurance and political will. For more, Africa 54 health correspondent Linord Moudou spoke with Dr. Ebere Okereke, technical adviser at the Tony Blair Institute for Global Change.